---
title: "Rani Therapeutics names Michelle Gilson to board as audit committee chair"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294820384.md"
description: "Rani Therapeutics has appointed Michelle Gilson to its board of directors, specifically naming her as the chair of the audit committee. Gilson previously served as CFO of Arcellx, which was acquired by Gilead in 2026, and has a background in biotechnology equity research at major investment banks."
datetime: "2026-08-04T12:01:57.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294820384.md)
  - [en](https://longbridge.com/en/news/294820384.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294820384.md)
generator: "portal-rs"
---

# Rani Therapeutics names Michelle Gilson to board as audit committee chair

-   Rani Therapeutics named Michelle Gilson to its board, appointing her audit committee chair. \* Gilson was most recently CFO of Arcellx, acquired by Gilead in 2026. \* Her earlier career included biotechnology equity research roles at major investment banks. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rani Therapeutics Holdings Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608040800PRIMZONEFULLFEED9802896) on August 04, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [RANI.US](https://longbridge.com/en/quote/RANI.US.md)
- [GILD.US](https://longbridge.com/en/quote/GILD.US.md)
- [ACLX.US](https://longbridge.com/en/quote/ACLX.US.md)

## Related News & Research

- [Parallax Volatility Advisers L.P. Trims Holdings in Gilead Sciences, Inc. $GILD](https://longbridge.com/en/news/297162579.md)
- [FDA approves daily HIV pill from Gilead designed to simplify treatment for some patients](https://longbridge.com/en/news/297236507.md)
- [Nvidia’s Biggest Customers Face a Painful New AI Bill](https://longbridge.com/en/news/297062287.md)
- [05:13 ETKeymed Biosciences Announces 2026 H1 Results and Business Updates](https://longbridge.com/en/news/296594656.md)
- [European Commission Expands Role of Gilead’s Trodelvy® in First-Line Metastatic Triple-Negative Breast Cancer Across PD-L1 Status | GILD Stock News](https://longbridge.com/en/news/296773236.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**